Michael Chia-shao Hsu, MD | |
325 East Eisenhower Pkwy, Suite 100, Ann Arbor, MI 48108 | |
(734) 936-7175 | |
Not Available |
Full Name | Michael Chia-shao Hsu |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 15 Years |
Location | 325 East Eisenhower Pkwy, Ann Arbor, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073526869 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 4301087449 (Michigan) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
Antibiotics are medicines used to treat infections or diseases caused by bacteria, such as some respiratory tract infections (including pneumonia and whooping cough), urinary tract infections, skin infections and infected wounds.
Is it possible to cure patients with unresectable colorectal liver metastases? Are complex surgeries safe for patients with extensive metastatic disease? How can we monitor and improve the quality of these surgical strategies? How can we improve surgical care for patients through research?
Inovio Pharmaceuticals, Inc. announced today it has received a U.S. Department of Defense Small Business Innovation Research Grant to advance the development of a low-cost, non-invasive surface electroporation (EP) delivery device and test its utility in combination with Inovio's novel synthetic DNA vaccines against viruses with bioterrorism potential, including hanta, puumala, arenavirus and pandemic influenza.
According to the Centers for Disease Control and Prevention, suicide was the 10th leading cause of death for children ages 5 to 11 in 2014. This was the first time suicide had shown up in the CDC's top ten leading causes of death for children in this age group.
Pepscan Therapeutics, the Netherlands based biotechnology firm focusing on protein mimicry technology for the generation of novel therapeutics, today announced that it has signed a Research and License Agreement with Tibotec Pharmaceuticals, Ireland. Under the agreement Pepscan using its CLIPS technology will work with Tibotec to develop novel therapeutic peptides against an undisclosed target.
› Verified 3 days ago
Entity Name | Kaiser Foundation Health Plan Of The Northwest |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Antibiotics are medicines used to treat infections or diseases caused by bacteria, such as some respiratory tract infections (including pneumonia and whooping cough), urinary tract infections, skin infections and infected wounds.
Is it possible to cure patients with unresectable colorectal liver metastases? Are complex surgeries safe for patients with extensive metastatic disease? How can we monitor and improve the quality of these surgical strategies? How can we improve surgical care for patients through research?
Inovio Pharmaceuticals, Inc. announced today it has received a U.S. Department of Defense Small Business Innovation Research Grant to advance the development of a low-cost, non-invasive surface electroporation (EP) delivery device and test its utility in combination with Inovio's novel synthetic DNA vaccines against viruses with bioterrorism potential, including hanta, puumala, arenavirus and pandemic influenza.
According to the Centers for Disease Control and Prevention, suicide was the 10th leading cause of death for children ages 5 to 11 in 2014. This was the first time suicide had shown up in the CDC's top ten leading causes of death for children in this age group.
Pepscan Therapeutics, the Netherlands based biotechnology firm focusing on protein mimicry technology for the generation of novel therapeutics, today announced that it has signed a Research and License Agreement with Tibotec Pharmaceuticals, Ireland. Under the agreement Pepscan using its CLIPS technology will work with Tibotec to develop novel therapeutic peptides against an undisclosed target.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Chia-shao Hsu, MD 3621 S State St, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | Michael Chia-shao Hsu, MD 325 East Eisenhower Pkwy, Suite 100, Ann Arbor, MI 48108 Ph: (734) 936-7175 |
News Archive
Antibiotics are medicines used to treat infections or diseases caused by bacteria, such as some respiratory tract infections (including pneumonia and whooping cough), urinary tract infections, skin infections and infected wounds.
Is it possible to cure patients with unresectable colorectal liver metastases? Are complex surgeries safe for patients with extensive metastatic disease? How can we monitor and improve the quality of these surgical strategies? How can we improve surgical care for patients through research?
Inovio Pharmaceuticals, Inc. announced today it has received a U.S. Department of Defense Small Business Innovation Research Grant to advance the development of a low-cost, non-invasive surface electroporation (EP) delivery device and test its utility in combination with Inovio's novel synthetic DNA vaccines against viruses with bioterrorism potential, including hanta, puumala, arenavirus and pandemic influenza.
According to the Centers for Disease Control and Prevention, suicide was the 10th leading cause of death for children ages 5 to 11 in 2014. This was the first time suicide had shown up in the CDC's top ten leading causes of death for children in this age group.
Pepscan Therapeutics, the Netherlands based biotechnology firm focusing on protein mimicry technology for the generation of novel therapeutics, today announced that it has signed a Research and License Agreement with Tibotec Pharmaceuticals, Ireland. Under the agreement Pepscan using its CLIPS technology will work with Tibotec to develop novel therapeutic peptides against an undisclosed target.
› Verified 3 days ago
Brian M Kelly, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2850 S Industrial Hwy Ste 400, Ann Arbor, MI 48104 Phone: 734-973-2400 | |
Edward A Hurvitz, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2205 Commonwealth Blvd, Ann Arbor, MI 48105 Phone: 734-936-7175 | |
Reina Nakamura, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 Phone: 734-936-7175 | |
Lisa A Diponio, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 325 East Eisenhower Pkwy, Suite 100, Ann Arbor, MI 48108 Phone: 734-936-7175 | |
Alecia Kupser Daunter, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2205 Commonwealth, Ann Arbor, MI 48105 Phone: 734-936-7175 | |
Ky Viet Dong Quach, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 Phone: 734-936-7175 |